defining rucaparib’s value in recurrent ovarian cancer
Published 6 years ago • 278 plays • Length 5:11Download video MP4
Download video MP3
Similar videos
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
6:34
bevacizumab’s value in recurrent ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
1:42
phase iii results for rucaparib in ovarian cancer
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
11:05
parp inhibitors in recurrent ovarian cancer
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
1:36
dr. coleman discusses the toxicities associated with rucaparib in patients with ovarian cancer
-
5:18
rucaparib for ovarian cancer
-
4:29
optimizing therapy in recurrent ovarian cancer
-
6:49
platinum-sensitive relapsed ovarian cancer: rucaparib
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer